News Focus
News Focus
icon url

north40000

09/05/17 2:08 PM

#310843 RE: biopharm #310842

Another observation from another board, biopharm:

"Cellectis death casts more doubt on CD123

They note that capillary leaks seem to be emerging as a target specific problem.

Nevertheless, Xencor/J&J's P3 project has managed to avoid the early stage safety failures. And I would note that XNCR is more or less unchanged this morning. What are they doing right?" ------------------>

"progress in the Labs of Dr Jedd Wolchok as evident by 2017 AACR poster #1651?"

Mussels, cancer, environment and more basic research in the labs of MSKCC:

http://www.newyorker.com/magazine/2017/09/11/cancers-invasion-equation

The article poses some interesting questions.
icon url

Threes

09/05/17 2:38 PM

#310847 RE: biopharm #310842

Looks like a long line of success and credibility in big circles.

They will not halt PS targeting , they WILL halt the financial bleeding spent in ways that cannot be financed to fruition without TOTAL decimation of current shareholders.
icon url

biopharm

09/05/17 4:19 PM

#310856 RE: biopharm #310842

Current positions of John S. Stafford III
Name Title Since
Ronin Capital LLC Founder, President & Chief Executive Officer 2001
Aware, Inc.
(Software) Independent Director 2011
Clinical Micro Sensors, Inc. Director -
All Optical Networks, Inc. Director -
Chicago Mercantile Exchange, Inc. Member -
Chicago Board Options Exchange, Inc. Member -
Chicago Board of Trade Member -
Zen Investments LLC Founder



Zen Investments? I am trying to find out all one could in regards to John Stafford and what has John Stafford done with Zen Investments?

As part of Ronin group ....I want to make sure PPHM is not sound off and dropped into Zen Investments or anything because it does not look to have any list of subsidiaries ....